Short-term attention and verbal fluency is decreased in restless legs syndrome patients

2010 ◽  
Vol 25 (15) ◽  
pp. 2641-2648 ◽  
Author(s):  
Stephany Fulda ◽  
Marie E. Beitinger ◽  
Simone Reppermund ◽  
Juliane Winkelmann ◽  
Thomas C. Wetter
Keyword(s):  
Restless Legs Syndrome ◽  
Verbal Fluency ◽  
Short Term ◽  
Restless Legs

scholarly journals Acute-Withdrawal Restless Legs Syndrome Following Abrupt Cessation of Short-Term Tramadol

2014 ◽  
Vol 11 (2) ◽  
pp. 204 ◽  
Author(s):  
Young-Min Park ◽  
Hye Kyeong Park ◽  
Leen Kim ◽  
Heon-Jeong Lee ◽  
Seung-Gul Kang
Keyword(s):  
Restless Legs Syndrome ◽  
Short Term ◽  
Abrupt Cessation ◽  
Restless Legs ◽  
Acute Withdrawal

Impaired short-term plasticity in restless legs syndrome: a pilot rTMS study

2018 ◽  
Vol 46 ◽  
pp. 1-4 ◽  
Author(s):  
Giuseppe Lanza ◽  
Bartolo Lanuzza ◽  
Debora Aricò ◽  
Mariagiovanna Cantone ◽  
Filomena Irene Ilaria Cosentino ◽  
...  
Keyword(s):  
Restless Legs Syndrome ◽  
Short Term ◽  
Short Term Plasticity ◽  
Restless Legs

The effectiveness of short-term cognitive behavioral therapy in the complex treatment of idiopathic restless legs syndrome with chronic insomnia

2021 ◽  
Vol LIII (2) ◽  
pp. 46-56
Author(s):  
Aleksey I. Melekhin
Keyword(s):  
Restless Legs Syndrome ◽  
Behavioral Therapy ◽  
Well Being ◽  
Sleep Hygiene ◽  
Cognitive Behavioral ◽  
Chronic Insomnia ◽  
Short Term ◽  
Restless Legs ◽  
Mental Well Being

Aim. To investigate the effectiveness of the short-term protocol of cognitive behavioral therapy RELEGS M. Hornyak et al. in complex treatment to improve the quality of sleep, reduce the symptoms of depression, anxiety, suicidal thoughts in patients with primary SBN comorbid with chronic insomnia. Methods. Study participants: 68 patients with primary restless legs syndrome with comorbid chronic insomnia. Women 56 (average age 52.110.3 years), men 12 (average age 50.39.4 years). The severity of restless legs syndrome is moderate to severe. The average age of the onset of the disease is 1848 years, the duration of the course of the disease is on average 1415 years. Taking various medications for the management of SBN for an average of 45 years. Study design: a randomized controlled trial, after screening 26 patients were assigned to the main group, underwent combined treatment, took a prolonged form of Pramipexole (Mirapex-PD, 1.5 mg.) and underwent the RELEGS CBT protocol (Restless Legs Skills program, Hornyak, Grossmann, 2018), which integrates the cognitive behavioral insomnia protocol (Morin, 2007) and Mindfulness-Based Stress therapy (Mindfulness-Based Stress Reduction, Bablas, 2016). The control group consisted of 24 people who received only general recommendations on sleep hygiene once. Both groups were treated with dopaminergic agonists under the supervision of a neurologist. Research methods: IRLS, ISI, DBAS-16, sleep diary analysis, actigraphy, BDI, SBQ-R, BAI. Results. The use of the CBT protocol in combination therapy with prolonged-acting dopaminergic agonists in patients with primary restless leg syndrome (mild and moderate severity) with comorbid chronic insomnia, in contrast to simple one-time general recommendations on sleep hygiene, is more effective for reducing dysfunctional behaviors, the spectrum of reinsurance and avoidance behavior both in relation to sleep and symptoms of restless legs. In patients with primary restless legs syndrome who underwent CBT, greater mental well-being was observed, which was expressed in a decrease in the severity of symptoms of insomnia, anxiety, and suicidal behavior after completion and persisted after 3 months of follow-up. Conclusion. As part of a personalized comprehensive approach, along with a drug-based approach and general recommendations for sleep hygiene, the use of short-term CBT (4 sessions, 60 minutes each) can significantly improve mental well-being, improve the quality of sleep of patients with restless legs syndrome with comorbid chronic insomnia.

Short-term effects of massage with olive oil on the severity of uremic restless legs syndrome: A double-blind placebo-controlled trial

2019 ◽  
Vol 44 ◽  
pp. 261-268 ◽  
Author(s):  
Morteza Nasiri ◽  
Mohammad Abbasi ◽  
Zeynab Yousefi Khosroabadi ◽  
Hossien Saghafi ◽  
Fahimeh Hamzeei ◽  
...  
Keyword(s):  
Olive Oil ◽  
Restless Legs Syndrome ◽  
Controlled Trial ◽  
Short Term ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Restless Legs ◽  
Short Term Effects

Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome☆

2005 ◽  
Vol 6 (2) ◽  
pp. 141-147 ◽  
Author(s):  
D.L. Bliwise ◽  
A. Freeman ◽  
C.D. Ingram ◽  
D.B. Rye ◽  
S. Chakravorty ◽  
...  
Keyword(s):  
Restless Legs Syndrome ◽  
Short Term ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Restless Legs ◽  
Short Term Trial ◽  
Term Trial

Impaired rTMS-induced short-term neuroplasticity in restless legs syndrome: a pilot study

2017 ◽  
Vol 10 (2) ◽  
pp. 365-366
Author(s):  
G. Lanza ◽  
M. Cantone ◽  
B. Lanuzza ◽  
D. Aricò ◽  
F.I.I. Cosentino ◽  
...  
Keyword(s):  
Pilot Study ◽  
Restless Legs Syndrome ◽  
Short Term ◽  
Restless Legs
Sign in / Sign up

Export Citation Format

Share Document